Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p168 has 89 genes in the original annotation. Currently, there are 75 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
5728	PTEN	10q23del \| BZS \| CWS1 \| DEC \| GLM2 \| MHAM \| MMAC1 \| PTEN1 \| TEP1	phosphatase and tensin homolog	10q23.3
1147	CHUK	IKBKA \| IKK-alpha \| IKK1 \| IKKA \| NFKBIKA \| TCF16	conserved helix-loop-helix ubiquitous kinase	10q24-q25
6934	TCF7L2	TCF-4 \| TCF4	transcription factor 7 like 2	10q25.3
2263	FGFR2	BBDS \| BEK \| BFR-1 \| CD332 \| CEK3 \| CFD1 \| ECT1 \| JWS \| K-SAM \| KGFR \| TK14 \| TK25	fibroblast growth factor receptor 2	10q26
90993	CREB3L1	OASIS	cAMP responsive element binding protein 3-like 1	11p11.2
3265	HRAS	C-BAS/HAS \| C-H-RAS \| C-HA-RAS1 \| CTLO \| H-RASIDX \| HAMSV \| HRAS1 \| RASH1 \| p21ras	Harvey rat sarcoma viral oncogene homolog	11p15.5
2950	GSTP1	DFN7 \| FAEES3 \| GST3 \| GSTP \| HEL-S-22 \| PI	glutathione S-transferase pi 1	11q13
5970	RELA	NFKB3 \| p65	v-rel avian reticuloendotheliosis viral oncogene homolog A	11q13
595	CCND1	BCL1 \| D11S287E \| PRAD1 \| U21B31	cyclin D1	11q13
3845	KRAS	C-K-RAS \| CFC2 \| K-RAS2A \| K-RAS2B \| K-RAS4A \| K-RAS4B \| KI-RAS \| KRAS1 \| KRAS2 \| NS \| NS3 \| RALD \| RASK2	Kirsten rat sarcoma viral oncogene homolog	12p12.1
1027	CDKN1B	CDKN4 \| KIP1 \| MEN1B \| MEN4 \| P27KIP1	cyclin-dependent kinase inhibitor 1B	12p13.1-p12
4193	MDM2	ACTFS \| HDMX \| hdm2	MDM2 proto-oncogene	12q14.3-q15
3479	IGF1	IGF-I \| IGFI \| MGF	insulin like growth factor 1	12q23.2
7184	HSP90B1	ECGP \| GP96 \| GRP94 \| HEL-S-125m \| HEL35 \| TRA1	heat shock protein 90kDa beta family member 1	12q24.2-q24.3
2308	FOXO1	FKH1 \| FKHR \| FOXO1A	forkhead box O1	13q14.1
5925	RB1	OSRC \| PPP1R130 \| RB \| p105-Rb \| pRb \| pp110	retinoblastoma 1	13q14.2
4792	NFKBIA	IKBA \| MAD-3 \| NFKBI	NFKB inhibitor alpha	14q13
6655	SOS2	NS9	SOS Ras/Rho guanine nucleotide exchange factor 2	14q21
207	AKT1	AKT \| CWS6 \| PKB \| PKB-ALPHA \| PRKBA \| RAC \| RAC-ALPHA	v-akt murine thymoma viral oncogene homolog 1	14q32.32
3320	HSP90AA1	EL52 \| HEL-S-65p \| HSP86 \| HSP89A \| HSP90A \| HSP90N \| HSPC1 \| HSPCA \| HSPCAL1 \| HSPCAL4 \| HSPN \| Hsp89 \| Hsp90 \| LAP-2 \| LAP2	heat shock protein 90kDa alpha family class A member 1	14q32.33
5604	MAP2K1	CFC3 \| MAPKK1 \| MEK1 \| MKK1 \| PRKMK1	mitogen-activated protein kinase kinase 1	15q22.1-q22.33
3480	IGF1R	CD221 \| IGFIR \| IGFR \| JTK13	insulin like growth factor 1 receptor	15q26.3
5595	MAPK3	ERK-1 \| ERK1 \| ERT2 \| HS44KDAP \| HUMKER1A \| P44ERK1 \| P44MAPK \| PRKM3 \| p44-ERK1 \| p44-MAPK	mitogen-activated protein kinase 3	16p11.2
1387	CREBBP	CBP \| KAT3A \| RSTS	CREB binding protein	16p13.3
23533	PIK3R5	F730038I15Rik \| FOAP-2 \| P101-PI3K \| p101	phosphoinositide-3-kinase regulatory subunit 5	17p13.1
7157	TP53	BCC7 \| LFS1 \| P53 \| TRP53	tumor protein p53	17p13.1
2064	ERBB2	CD340 \| HER-2 \| HER-2/neu \| HER2 \| MLN 19 \| NEU \| NGL \| TKR1	erb-b2 receptor tyrosine kinase 2	17q12
2885	GRB2	ASH \| EGFRBP-GRB2 \| Grb3-3 \| MST084 \| MSTP084 \| NCKAP2	growth factor receptor bound protein 2	17q24-q25
596	BCL2	Bcl-2 \| PPP1R50	B-cell CLL/lymphoma 2	18q21.3
5605	MAP2K2	CFC4 \| MAPKK2 \| MEK2 \| MKK2 \| PRKMK2	mitogen-activated protein kinase kinase 2	19p13.3
898	CCNE1	CCNE \| pCCNE1	cyclin E1	19q12
208	AKT2	HIHGHH \| PKBB \| PKBBETA \| PRKBB \| RAC-BETA	v-akt murine thymoma viral oncogene homolog 2	19q13.1-q13.2
5296	PIK3R2	MPPH \| MPPH1 \| P85B \| p85 \| p85-BETA	phosphoinositide-3-kinase regulatory subunit 2	19q13.2-q13.4
354	KLK3	APS \| KLK2A1 \| PSA \| hK3	kallikrein related peptidase 3	19q13.41
4893	NRAS	ALPS4 \| CMNS \| N-ras \| NCMS \| NRAS1 \| NS6	neuroblastoma RAS viral (v-ras) oncogene homolog	1p13.2
8503	PIK3R3	p55 \| p55-GAMMA \| p55PIK	phosphoinositide-3-kinase regulatory subunit 3	1p34.1
1870	E2F2	E2F-2	E2F transcription factor 2	1p36
5293	PIK3CD	APDS \| IMD14 \| P110DELTA \| PI3K \| p110D	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta	1p36.2
2475	MTOR	FRAP \| FRAP1 \| FRAP2 \| RAFT1 \| RAPT1 \| SKS	mechanistic target of rapamycin	1p36.2
842	CASP9	APAF-3 \| APAF3 \| ICE-LAP6 \| MCH6 \| PPP1R56	caspase 9	1p36.21
3645	INSRR	IRR	insulin receptor-related receptor	1q21-q23
10000	AKT3	MPPH \| MPPH2 \| PKB-GAMMA \| PKBG \| PRKBG \| RAC-PK-gamma \| RAC-gamma \| STK-2	v-akt murine thymoma viral oncogene homolog 3	1q44
5594	MAPK1	ERK \| ERK-2 \| ERK2 \| ERT1 \| MAPK2 \| P42MAPK \| PRKM1 \| PRKM2 \| p38 \| p40 \| p41 \| p41mapk \| p42-MAPK	mitogen-activated protein kinase 1	22q11.21
5155	PDGFB	IBGC5 \| PDGF-2 \| PDGF2 \| SIS \| SSV \| c-sis	platelet derived growth factor subunit B	22q13.1
468	ATF4	CREB-2 \| CREB2 \| TAXREB67 \| TXREB	activating transcription factor 4	22q13.1
2033	EP300	KAT3B \| RSTS2 \| p300	E1A binding protein p300	22q13.2
83439	TCF7L1	TCF-3 \| TCF3	transcription factor 7 like 1	2p11.2
7039	TGFA	TFGA	transforming growth factor alpha	2p13
6716	SRD5A2	-	steroid 5 alpha-reductase 2	2p23
1385	CREB1	CREB \| CREB-1	cAMP responsive element binding protein 1	2q34
1499	CTNNB1	CTNNB \| MRD19 \| armadillo	catenin beta 1	3p21
5894	RAF1	CMD1NN \| CRAF \| NS5 \| Raf-1 \| c-Raf	Raf-1 proto-oncogene, serine/threonine kinase	3p25
2932	GSK3B	-	glycogen synthase kinase 3 beta	3q13.3
5291	PIK3CB	P110BETA \| PI3K \| PI3KBETA \| PIK3C1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta	3q22.3
5290	PIK3CA	CLOVE \| CWS5 \| MCAP \| MCM \| MCMTC \| PI3K \| p110-alpha	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	3q26.3
5156	PDGFRA	CD140A \| GAS9 \| PDGFR-2 \| PDGFR2 \| RHEPDGFRA	platelet derived growth factor receptor alpha	4q12
4790	NFKB1	CVID12 \| EBP-1 \| KBF1 \| NF-kB1 \| NF-kappa-B \| NF-kappaB \| NFKB-p105 \| NFKB-p50 \| NFkappaB \| p105 \| p50	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1	4q24
1950	EGF	HOMG4 \| URG	epidermal growth factor	4q25
51176	LEF1	LEF-1 \| TCF10 \| TCF1ALPHA \| TCF7L3	lymphoid enhancer binding factor 1	4q25
56034	PDGFC	FALLOTEIN \| SCDGF	platelet derived growth factor C	4q32
5295	PIK3R1	AGM7 \| GRB1 \| IMD36 \| p85 \| p85-ALPHA	phosphoinositide-3-kinase regulatory subunit 1	5q13.1
6932	TCF7	TCF-1	transcription factor 7 (T-cell specific, HMG-box)	5q31.1
5159	PDGFRB	CD140B \| IBGC4 \| IMF1 \| JTK12 \| KOGS \| PDGFR \| PDGFR-1 \| PDGFR1 \| PENTT	platelet derived growth factor receptor beta	5q33.1
3326	HSP90AB1	D6S182 \| HSP84 \| HSP90B \| HSPC2 \| HSPCB	heat shock protein 90kDa alpha family class B member 1	6p12
1026	CDKN1A	CAP20 \| CDKN1 \| CIP1 \| MDA-6 \| P21 \| SDI1 \| WAF1 \| p21CIP1	cyclin-dependent kinase inhibitor 1A	6p21.2
1871	E2F3	E2F-3	E2F transcription factor 3	6p22
1956	EGFR	ERBB \| ERBB1 \| HER1 \| NISBD2 \| PIG61 \| mENA	epidermal growth factor receptor	7p12
9586	CREB5	CRE-BPA \| CREB-5	cAMP responsive element binding protein 5	7p15.1
5154	PDGFA	PDGF-A \| PDGF1	platelet derived growth factor subunit A	7p22
673	BRAF	B-RAF1 \| BRAF1 \| NS7 \| RAFB1	B-Raf proto-oncogene, serine/threonine kinase	7q34
3551	IKBKB	IKK-beta \| IKK2 \| IKKB \| IMD15 \| NFKBIKB	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta	8p11.2
2260	FGFR1	BFGFR \| CD331 \| CEK \| FGFBR \| FGFR-1 \| FLG \| FLT-2 \| FLT2 \| HBGFR \| HH2 \| HRTFDS \| KAL2 \| N-SAM \| OGD \| bFGF-R-1	fibroblast growth factor receptor 1	8p11.23-p11.22
9134	CCNE2	CYCE2	cyclin E2	8q22.1
10488	CREB3	LUMAN \| LZIP \| sLZIP	cAMP responsive element binding protein 3	9p13.3
367	AR	AIS \| AR8 \| DHTR \| HUMARA \| HYSP1 \| KD \| NR3C4 \| SBMA \| SMAX1 \| TFM	androgen receptor	Xq12